Ocean Biomedical, Inc.
OCEA· OTC
OCEAOcean Biomedical, Inc.
Filed May 24, 2023 · 10-Q · 54 days after period end · 0001493152-23-018924
| Metric | Q1 2023 | Q1 2022 |
|---|---|---|
| Net Income | -$72.09M | -$165.71K |
| EPS Diluted | -$2.90 | -$0.23 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Ocean Biomedical, Inc. · CIK 1869974 · Engraved from SEC EDGAR
ended Mar 31, 2023 · filed May 24, 2023 · 54 d after period end
